Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Sepsis Diagnosis and Treatment, Immune Response and Inflammation, SARS-CoV-2 and COVID-19 Research, and Kawasaki Disease and Coronary Complications.
Molecular mimicry in multisystem inflammatory syndrome in children
Identification and transcriptomic assessment of latent profile pediatric septic shock phenotypes
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network.
SERUM HUMANIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE-ORGAN DYSFUNCTION SYNDROME.
Revisiting Post-ICU Admission Fluid Balance Across Pediatric Sepsis Mortality Risk Strata: A Secondary Analysis of a Prospective Observational Cohort Study.
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
Whole blood transcriptomics identifies subclasses of pediatric septic shock
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs*
Serum renin and prorenin concentrations predict severe persistent acute kidney injury and mortality in pediatric septic shock.
Variation in Early Anakinra Use and <scp>Short‐Term</scp> Outcomes in Multisystem Inflammatory Syndrome in Children
Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
SERUM SOLUBLE ENDOGLIN IN PEDIATRIC SEPTIC SHOCK-ASSOCIATED MULTIPLE ORGAN DYSFUNCTION SYNDROME.
A distinct cross-reactive autoimmune response in multisystem inflammatory syndrome in children (MIS-C)
Serum Humanin in Pediatric Septic Shock Associated Multiple Organ Dysfunction Syndrome
Prognostic and Predictive Value of Endothelial Dysfunction Biomarkers in Sepsis-Associated Acute Kidney Injury: Risk Stratified Analysis from a Prospective Observational Cohort of Pediatric Septic Shock
Serum Soluble Endoglin in Pediatric Septic Shock Associated Multiple Organ Dysfunction Syndrome.
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children
<i>DDX58</i> Is Associated With Susceptibility to Severe Influenza Virus Infection in Children and Adolescents
Integrated PERSEVERE and endothelial biomarker risk model predicts MODS in pediatric septic shock: A retrospective observational study
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents